High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer-Reference-Cited by-同舟云学术

High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer

Published:2005-07 Issue:1 Volume:98 Page:92-98
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Bellone Stefania,Watts Katherine,Cane' Stefania,Palmieri Michela,Cannon Martin J.,Burnett Alexander,Roman Juan J.,Pecorelli Sergio,Santin Alessandro D.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference38 articles.

1. Cancer statistics 2004;Jemal;CA Cancer J. Clin.,2004

2. Two pathogenetic types of endometrial carcinoma;Bohkman;Gynecol. Oncol.,1983

3. Current treatment for endometrial cancer;Santin;Exp. Opin. Anticancer Ther.,2004

4. Endometrial papillary serous carcinoma: patterns of spread and treatment;Nicklin;Clin. Obstet. Gynecol.,1996

5. Uterine papillary serous carcinoma: patterns of metastatic spread;Goff;Gynecol. Oncol.,1994

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of neck adipose tissue in lymph node metastasis of head and neck cancer;Frontiers in Oncology;2024-05-10

2. Circulating Adipocytokines and Insulin Like-Growth Factors and Their Modulation in Obesity-Associated Endometrial Cancer;Cancers;2024-01-26

3. The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling;International Journal of Molecular Sciences;2023-12-13

4. Analysis of the Occurrence of Predicative Factors of Chronic Fatigue in Female Patients with Cancer of the Reproductive Organs with Respect to Stage of Treatment;International Journal of Environmental Research and Public Health;2023-02-20

5. The roles and clinical applications of interleukins in endometrial carcinoma;Frontiers in Oncology;2022-11-30